yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q27489903-35A78DB7-4C2E-40AB-B3DF-658F86AB0938
Q27489903-35A78DB7-4C2E-40AB-B3DF-658F86AB0938
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27489903-35A78DB7-4C2E-40AB-B3DF-658F86AB0938
Expert opinion on the treatment of patients with chronic hepatitis C
P2860
Q27489903-35A78DB7-4C2E-40AB-B3DF-658F86AB0938
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27489903-35A78DB7-4C2E-40AB-B3DF-658F86AB0938
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64d7aed18b2f0eb01c9a66c9f820f4faf29036c1
P2860
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment.